Nasdaq · CIK 0001070494
ACAD ACADIA PHARMACEUTICALS INC
Insider trading from SEC Form 4. Last filing Jun 5, 2025. Close $19.78 on Oct 9, 2026, +1% from the 52-week low and -35% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
14
with a Form 4 at this company
Price and insider trades, last year
ACADOct 9, 2026 · close 19.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at ACADIA PHARMACEUTICALS INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Laura Brege director sell | $315k 14,446 shares | -49% | +54% from low-2% from high | |
| 17Weak | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER sell | $50k 2,000 shares | -3% | +58% from low0% from high | |
| 17Weak | James Kihara PRINCIPAL ACCOUNTING OFFICER sell | $90k 4,000 shares | -16% | +58% from low0% from high | |
| 2Weak | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER sell | $51k 3,498 shares | -5% | +6% from low-27% from high | |
| 0Weak | James Kihara PRINCIPAL ACCOUNTING OFFICER sell | $19k 1,327 shares | -5% | +6% from low-27% from high | |
| 0Weak | James Kihara PRINCIPAL ACCOUNTING OFFICER sell | $15k 1,028 shares | -4% | 0% from low-31% from high | |
| 1Weak | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER sell | $40k 2,708 shares | -4% | 0% from low-31% from high | |
| 2Weak | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER sell | $54k 3,171 shares | -5% | +19% from low-16% from high | |
| 0Weak | James Kihara PRINCIPAL ACCOUNTING OFFICER sell | $19k 1,095 shares | -5% | +19% from low-16% from high | |
| 44Moderate | Elizabeth A. Garofalo director sell | $90k 4,919 shares | -22% | +27% from low-11% from high | |
| 2Weak | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER sell | $15k 773 shares | -1% | +36% from low-4% from high | |
| 0Weak | James Kihara PRINCIPAL ACCOUNTING OFFICER sell | $9,481 475 shares | -2% | +36% from low-4% from high | |
| 18Weak | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER sell | $172k 10,259 shares | -16% | - | |
| 8Weak | James Kihara PRINCIPAL ACCOUNTING OFFICER sell | $68k 4,073 shares | -17% | - | |
| 16Weak | Brendan Teehan EVP, COO, HEAD OF COMMERCIAL sell | $174k 10,329 shares | -14% | - |
Transactions
The last 86 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | Laura Brege director | SOpen-market sale Common Stock | -14,446 | $21.78 | $315k | 15,095 | Jun 5, 2025 |
| May 29, 2025 | Baker Bros. Advisors LP director, owner | AGrant or award Common Stockindirect: See Footnotes | +16,214 | $0.00 | $0 | 3,658,735 | Jun 2, 2025 |
| May 29, 2025 | Daniel B Soland director | MOption exercise Common Stock | +9,387 | - | - | 44,041 | Jun 2, 2025 |
| May 29, 2025 | Adora Ndu director | MOption exercise Common Stock | +9,387 | - | - | 24,801 | Jun 2, 2025 |
| May 29, 2025 | Edmund Harrigan director | MOption exercise Common Stock | +9,387 | - | - | 35,041 | Jun 2, 2025 |
| May 29, 2025 | Elizabeth A. Garofalo director | MOption exercise Common Stock | +9,387 | - | - | 26,982 | Jun 2, 2025 |
| May 29, 2025 | James M Daly director | MOption exercise Common Stock | +9,387 | - | - | 34,041 | Jun 2, 2025 |
| May 29, 2025 | Laura Brege director | MOption exercise Common Stock | +9,387 | - | - | 29,541 | Jun 2, 2025 |
| May 29, 2025 | Laura Brege director | MOption exercise Restricted Stock Unitsderivative | -9,387 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | James M Daly director | MOption exercise Restricted Stock Unitsderivative | -9,387 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | Adora Ndu director | MOption exercise Restricted Stock Unitsderivative | -9,387 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | Baker Bros. Advisors LP director, owner | AGrant or award Common Stockindirect: See Footnotes | +16,214 | $0.00 | $0 | 39,365,965 | Jun 2, 2025 |
| May 29, 2025 | Elizabeth A. Garofalo director | MOption exercise Restricted Stock Unitsderivative | -9,387 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | Edmund Harrigan director | MOption exercise Restricted Stock Unitsderivative | -9,387 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | Daniel B Soland director | MOption exercise Restricted Stock Unitsderivative | -9,387 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | Elizabeth A. Garofalo director | AGrant or award Director Stock Options (Right to Buy)derivative | +13,793 | $0.00 | $0 | 13,793 | Jun 2, 2025 |
| May 29, 2025 | Adora Ndu director | AGrant or award Director Stock Options (Right to Buy)derivative | +13,793 | $0.00 | $0 | 13,793 | Jun 2, 2025 |
| May 29, 2025 | Edmund Harrigan director | AGrant or award Director Stock Options (Right to Buy)derivative | +13,793 | $0.00 | $0 | 13,793 | Jun 2, 2025 |
| May 29, 2025 | Daniel B Soland director | AGrant or award Director Stock Options (Right to Buy)derivative | +13,793 | $0.00 | $0 | 13,793 | Jun 2, 2025 |
| May 29, 2025 | James M Daly director | AGrant or award Director Stock Options (Right to Buy)derivative | +13,793 | $0.00 | $0 | 13,793 | Jun 2, 2025 |
| May 29, 2025 | Laura Brege director | AGrant or award Director Stock Options (Right to Buy)derivative | +13,793 | $0.00 | $0 | 13,793 | Jun 2, 2025 |
| May 29, 2025 | Laura Brege director | AGrant or award Restricted Stock Unitsderivative | +8,107 | $0.00 | $0 | 8,107 | Jun 2, 2025 |
| May 29, 2025 | Daniel B Soland director | AGrant or award Restricted Stock Unitsderivative | +8,107 | $0.00 | $0 | 8,107 | Jun 2, 2025 |
| May 29, 2025 | Adora Ndu director | AGrant or award Restricted Stock Unitsderivative | +8,107 | $0.00 | $0 | 8,107 | Jun 2, 2025 |
| May 29, 2025 | Edmund Harrigan director | AGrant or award Restricted Stock Unitsderivative | +8,107 | $0.00 | $0 | 8,107 | Jun 2, 2025 |
| May 29, 2025 | Elizabeth A. Garofalo director | AGrant or award Restricted Stock Unitsderivative | +8,107 | $0.00 | $0 | 8,107 | Jun 2, 2025 |
| May 29, 2025 | James M Daly director | AGrant or award Restricted Stock Unitsderivative | +8,107 | $0.00 | $0 | 8,107 | Jun 2, 2025 |
| May 29, 2025 | Baker Bros. Advisors LP director, owner | AGrant or award Non- Qualified Stock Option (right to buy)derivativeindirect: See Footnotes | +27,586 | $0.00 | $0 | 27,586 | Jun 2, 2025 |
| May 29, 2025 | Baker Bros. Advisors LP director, owner | AGrant or award Non- Qualified Stock Option (right to buy)derivativeindirect: See Footnotes | +27,586 | $0.00 | $0 | 27,586 | Jun 2, 2025 |
| May 16, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -2,000 | $25.00 | $50k | 62,130 | May 19, 2025 |
| May 16, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | SOpen-market sale Common Stock10b5-1 | -2,000 | $25.00 | $50k | 22,395 | May 19, 2025 |
| May 16, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | SOpen-market sale Common Stock10b5-1 | -2,000 | $20.00 | $40k | 20,395 | May 19, 2025 |
| May 1, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Common Stock | +2,596 | - | - | 24,853 | May 2, 2025 |
| May 1, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +6,815 | - | - | 66,271 | May 2, 2025 |
| May 2, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | SOpen-market sale Common Stock10b5-1 | -1,327 | $14.60 | $19k | 23,526 | May 2, 2025 |
| May 2, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -3,498 | $14.60 | $51k | 62,773 | May 2, 2025 |
| May 1, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -6,815 | $0.00 | $0 | 13,630 | May 2, 2025 |
| May 1, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Restricted Stock Unitsderivative | -2,596 | $0.00 | $0 | 5,192 | May 2, 2025 |
| Apr 5, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Common Stock | +2,010 | - | - | 23,285 | Apr 8, 2025 |
| Apr 5, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +5,275 | - | - | 62,164 | Apr 8, 2025 |
| Apr 8, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | SOpen-market sale Common Stock10b5-1 | -1,028 | $14.82 | $15k | 22,257 | Apr 8, 2025 |
| Apr 8, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -2,708 | $14.82 | $40k | 59,456 | Apr 8, 2025 |
| Apr 5, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -5,275 | $0.00 | $0 | 5,276 | Apr 8, 2025 |
| Apr 5, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Restricted Stock Unitsderivative | -2,010 | $0.00 | $0 | 2,010 | Apr 8, 2025 |
| Mar 25, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +6,178 | - | - | 60,060 | Mar 26, 2025 |
| Mar 25, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Common Stock | +2,142 | - | - | 22,370 | Mar 26, 2025 |
| Mar 24, 2025 | Elizabeth H.Z. Thompson EVP, Head of Research & Dev | AGrant or award Stock Option (Right to Buy)derivative | +91,395 | $0.00 | $0 | 91,395 | Mar 26, 2025 |
| Mar 24, 2025 | Adams Catherine Owen Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +319,976 | $0.00 | $0 | 319,976 | Mar 26, 2025 |
| Mar 26, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -3,171 | $17.05 | $54k | 56,889 | Mar 26, 2025 |
| Mar 24, 2025 | Jennifer J Rhodes EVP, CHIEF LEGAL OFFICER, SEC | AGrant or award Stock Option (Right to Buy)derivative | +102,289 | $0.00 | $0 | 102,289 | Mar 26, 2025 |
| Mar 24, 2025 | Elizabeth H.Z. Thompson EVP, Head of Research & Dev | AGrant or award Restricted Stock Unitsderivative | +26,861 | $0.00 | $0 | 26,861 | Mar 26, 2025 |
| Mar 24, 2025 | Adams Catherine Owen Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +94,039 | $0.00 | $0 | 94,039 | Mar 26, 2025 |
| Mar 26, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | SOpen-market sale Common Stock10b5-1 | -1,095 | $17.05 | $19k | 21,275 | Mar 26, 2025 |
| Mar 24, 2025 | Jennifer J Rhodes EVP, CHIEF LEGAL OFFICER, SEC | AGrant or award Restricted Stock Unitsderivative | +30,062 | $0.00 | $0 | 30,062 | Mar 26, 2025 |
| Mar 24, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +110,761 | $0.00 | $0 | 110,761 | Mar 26, 2025 |
| Mar 24, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +22,152 | $0.00 | $0 | 22,152 | Mar 26, 2025 |
| Mar 24, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | AGrant or award Restricted Stock Unitsderivative | +32,552 | $0.00 | $0 | 32,552 | Mar 26, 2025 |
| Mar 24, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | AGrant or award Restricted Stock Unitsderivative | +6,510 | $0.00 | $0 | 6,510 | Mar 26, 2025 |
| Mar 25, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Restricted Stock Unitsderivative | -2,142 | $0.00 | $0 | 6,426 | Mar 26, 2025 |
| Mar 25, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -6,178 | $0.00 | $0 | 18,536 | Mar 26, 2025 |
| Mar 5, 2025 | Elizabeth A. Garofalo director | SOpen-market sale Common Stock | -4,919 | $18.23 | $90k | 17,595 | Mar 6, 2025 |
| Feb 23, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +1,353 | - | - | 54,655 | Feb 25, 2025 |
| Feb 23, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Common Stock | +840 | - | - | 20,703 | Feb 25, 2025 |
| Feb 24, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -773 | $19.96 | $15k | 53,882 | Feb 25, 2025 |
| Feb 24, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | SOpen-market sale Common Stock10b5-1 | -475 | $19.96 | $9,481 | 20,228 | Feb 25, 2025 |
| Feb 23, 2025 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -1,353 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 23, 2025 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Restricted Stock Unitsderivative | -840 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Dec 9, 2024 | Thomas Garner EVP, Chief Commercial Officer | AGrant or award Stock Option (Right to Buy)derivative | +235,849 | $0.00 | $0 | 235,849 | Dec 10, 2024 |
| Dec 9, 2024 | Thomas Garner EVP, Chief Commercial Officer | AGrant or award Restricted Stock Unitsderivative | +45,372 | $0.00 | $0 | 45,372 | Dec 10, 2024 |
| Nov 17, 2024 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Common Stock | +3,965 | - | - | 19,971 | Nov 19, 2024 |
| Nov 17, 2024 | Brendan Teehan EVP, COO, HEAD OF COMMERCIAL | MOption exercise Common Stock | +9,913 | - | - | 62,521 | Nov 19, 2024 |
| Nov 17, 2024 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +9,913 | - | - | 53,648 | Nov 19, 2024 |
| Nov 17, 2024 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +9,913 | - | - | 63,561 | Nov 19, 2024 |
| Nov 17, 2024 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Common Stock | +3,965 | - | - | 23,936 | Nov 19, 2024 |
| Nov 17, 2024 | Brendan Teehan EVP, COO, HEAD OF COMMERCIAL | MOption exercise Common Stock | +9,913 | - | - | 72,434 | Nov 19, 2024 |
| Nov 19, 2024 | Brendan Teehan EVP, COO, HEAD OF COMMERCIAL | SOpen-market sale Common Stock10b5-1 | -10,329 | $16.81 | $174k | 62,105 | Nov 19, 2024 |
| Nov 19, 2024 | James Kihara PRINCIPAL ACCOUNTING OFFICER | SOpen-market sale Common Stock10b5-1 | -4,073 | $16.81 | $68k | 19,863 | Nov 19, 2024 |
| Nov 19, 2024 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -10,259 | $16.81 | $172k | 53,302 | Nov 19, 2024 |
| Nov 17, 2024 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -9,913 | $0.00 | $0 | 9,913 | Nov 19, 2024 |
| Nov 17, 2024 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Restricted Stock Unitsderivative | -3,965 | $0.00 | $0 | 3,966 | Nov 19, 2024 |
| Nov 17, 2024 | Brendan Teehan EVP, COO, HEAD OF COMMERCIAL | MOption exercise Restricted Stock Unitsderivative | -9,913 | $0.00 | $0 | 9,913 | Nov 19, 2024 |
| Nov 17, 2024 | Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -9,913 | $0.00 | $0 | 9,913 | Nov 19, 2024 |
| Nov 17, 2024 | James Kihara PRINCIPAL ACCOUNTING OFFICER | MOption exercise Restricted Stock Unitsderivative | -3,965 | $0.00 | $0 | 3,966 | Nov 19, 2024 |
| Nov 17, 2024 | Brendan Teehan EVP, COO, HEAD OF COMMERCIAL | MOption exercise Restricted Stock Unitsderivative | -9,913 | $0.00 | $0 | 9,913 | Nov 19, 2024 |
| Oct 12, 2024 | Adora Ndu director | MOption exercise Common Stock | +4,381 | - | - | 15,414 | Oct 15, 2024 |
| Oct 12, 2024 | Adora Ndu director | MOption exercise Restricted Stock Unitsderivative | -4,381 | $0.00 | $0 | 0 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Baker Bros. Advisors LPdirector, owner
- Laura Bregedirector
- James M Dalydirector
- Elizabeth A. Garofalodirector
- Thomas GarnerEVP, Chief Commercial Officer
- Edmund Harrigandirector
- James KiharaPRINCIPAL ACCOUNTING OFFICER
- Adora Ndudirector
- Adams Catherine OwenChief Executive Officer
- Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC
- Daniel B Solanddirector
- Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
- Brendan TeehanEVP, COO, HEAD OF COMMERCIAL
- Elizabeth H.Z. ThompsonEVP, Head of Research & Dev
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.